Cognition Disorders Recruiting Phase 4 Trials for Dexmedetomidine (DB00633)

Also known as: Cognitive Disorder / Cognitive Disorders / Cognition Disorder / Cognitive Dysfunction / Cognitive Dysfunctions / Cognitive disorder (disorder)

IndicationStatusPhase
DBCOND0027877 (Cognition Disorders)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04289142Cognitive Outcomes After Dexmedetomidine Sedation in Cardiac Surgery PatientsPrevention